Skip to main content
Skip to Footer

American Journal of Psychiatry

  • Volume 179
  • Number 7
  • July 2022

Editor’s Note

Editorials

Reviews and Overviews

Publication date: 01 July 2022

Pages458–469

Anhedonia—the loss of pleasure or lack of reactivity to pleasurable stimuli—remains a formidable treatment challenge across neuropsychiatric disorders. In major depressive disorder, anhedonia has been linked to poor disease course, worse response to ...

https://doi.org/10.1176/appi.ajp.20220423

Articles

Publication date: 12 April 2022

Pages482–489

Objective:The authors evaluated AKL-T03, an investigational digital intervention delivered through a video game–based interface, designed to target the fronto-parietal network to enhance functional domains for attentional control. AKL-T03 was tested in ...

https://doi.org/10.1176/appi.ajp.21020125

Publication date: 18 May 2022

Pages490–499

Objective:Altered glutamatergic neurotransmission is implicated in the pathogenesis of major depressive disorder. AXS-05 (dextromethorphan-bupropion) is an oral NMDA receptor antagonist and sigma-1 receptor agonist, which utilizes inhibition of CYP2D6 to ...

https://doi.org/10.1176/appi.ajp.21080800

Publication date: 18 May 2022

Pages500–508

Objective:The study objective was to investigate the predictive value of functional connectivity changes induced by acute repetitive transcranial magnetic stimulation (rTMS) for clinical response in treatment-resistant depression.Methods:Cross-sectional ...

https://doi.org/10.1176/appi.ajp.21050541

Priority Data Letter

Past Issues

View Issues Archive
No.7
View Issue
1 Jul 2024

Vol. 181 | No. 7

No.6
View Issue
1 Jun 2024

Vol. 181 | No. 6

No.5
View Issue
1 May 2024

Vol. 181 | No. 5

No.4
View Issue
1 Apr 2024

Vol. 181 | No. 4